Heart Valve Disease Clinical Trial
— CopenHeartVROfficial title:
CopenHeartVR - A Randomized Clinical Trial Investigating the Effect of Integrated Rehabilitation Versus Usual Care Without Physical Exercise After Heart Valve Surgery.
The aim of the study is to investigate the effect of an integrated rehabilitation programme,
consisting of physical exercise training and psycho-educational consultations, for patients
after heart valve surgery.
The hypothesis is that integrated rehabilitation can improve physical capacity measured by
V02 peak, self-rated mental health and life quality by validated questionnaires such as
SF-36, and other objective parameters such as cardiac-specific biomarkers and
echocardiographic measurements.
Status | Completed |
Enrollment | 147 |
Est. completion date | May 2015 |
Est. primary completion date | May 2015 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Admitted to hospital for elective heart valve surgery at Rigshospitalet, Denmark - 18 years or older - Speak and understand Danish - Providing written informed consent Exclusion Criteria: - Known ischemic heart disease prior to heart valve surgery - Is included in an other clinical trial investigating the effects of physical training and psycho-educational intervention - Unable to understand and cooperate to study instructions - Pregnant and/or breast feeding - Performing exercise training at high level and several times a week - No written informed consent |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
Denmark | Rigshospitalet / Copenhagen University Hospital | Copenhagen |
Lead Sponsor | Collaborator |
---|---|
Rigshospitalet, Denmark |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in physical capacity | Measured by Vo2peak by ergospirometry testing | 1,4,12 months | Yes |
Secondary | Change in self-rated mental health and quality of life | Measured by total score and the mental health component scale (MSC) in the SF-36 questionnaire. | 0, 1, 4, 6, 12 and 24 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Completed |
NCT02527629 -
Aortic Replacement Using Individualised Regenerative Allografts - ARISE (the "Surveillance")
|
||
Completed |
NCT01178710 -
Effect of Simvastatin on Cardiac Function
|
N/A | |
Completed |
NCT01426776 -
Effect of Heart Valve Replacement on Cheyne-Stokes Respiration
|
N/A | |
Completed |
NCT00581399 -
A Randomized Multicenter Clinical Study On the High Vacuum Body Cavity Drainage System Following Open Heart Surgery
|
Phase 2 | |
Withdrawn |
NCT00187304 -
ACTION - Anticoagulation Treatment Influence on Post-operative Patients
|
Phase 4 | |
Terminated |
NCT00700947 -
Using Beta Blockers to Treat Mitral Regurgitation
|
Phase 1 | |
Recruiting |
NCT02650388 -
Frailty and Cognitive Function Assessment of TAVI Patients
|
Phase 4 | |
Recruiting |
NCT02574650 -
Early Feasibility of the Mitralign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS) Also Known as TriAlign™.
|
N/A | |
Completed |
NCT01996657 -
D-dimer and Oral Anticoagulation Therapy in Patients With Mechanical Valve Replacement
|
N/A | |
Terminated |
NCT00598936 -
A Prospective Study With a New Device for the Monitoring of Cerebral Oxygenation on Cardiac Surgery Patients
|
Phase 1 | |
Terminated |
NCT01812174 -
On-X Heart Valve - 17mm Aortic and 23mm Mitral
|
N/A | |
Recruiting |
NCT03225612 -
Safety and Performance of the Trialign Percutaneous Tricuspid Valve Annuloplasty System (PTVAS)
|
N/A | |
Completed |
NCT01384643 -
Effect of Propofol on Renal Injury in Patients Undergoing Valvular Heart Surgery
|
Phase 4 | |
Active, not recruiting |
NCT00291525 -
Randomized On-X Anticoagulation Trial
|
N/A | |
Completed |
NCT02867930 -
Comparative Effects of Dexmedetomidine and Ketofol for Sedation in Patients Undergoing Trans-esophageal Echocardiography
|
Phase 4 | |
Recruiting |
NCT02478008 -
A Clinical Study of the CardiAQ™ TMVI System (Transapical DS)
|
N/A | |
Completed |
NCT02790008 -
Magnetic Resonance Imaging and Fibrosis
|
||
Completed |
NCT02587039 -
An Intervention to Reduce Delirium After Cardiac Surgery
|
N/A | |
Recruiting |
NCT01855737 -
The Study of Warfarin Maintenance Dose in Chinese Patients
|
Phase 4 |